DynaMiTES – A dynamic cell culture platform for in vitro drug testing PART 1 – Engineering of microfluidic system and technical simulations

Graphical abstract Figure. No Caption available. ABSTRACT Conventional safety and efficacy test models, such as animal experiments or static in vitro cell culture models, can often not reliably predict the most promising drug candidates. Therefore, a novel microfluidic cell culture platform, called Dynamic Micro Tissue Engineering System (DynaMiTES), was designed to allow online analysis of drugs permeating through barrier forming tissues under dynamic conditions combined with monitoring of the transepithelial electrical resistance (TEER) by electrodes optimized for homogeneous current distribution. A variety of pre‐cultivated cell culture inserts can be integrated and exposed to well controlled dynamic micro flow conditions, resulting in a tightly regulated exposure of the cells to tested drugs, drug formulations and shear forces. With these qualities, the new system can provide more relevant information compared to static measurements. As a first in vitro model, a three‐dimensional hemicornea construct consisting of human keratocytes (HCK‐Ca) and epithelial cells (HCE‐T) was successfully tested in the DynaMiTES. Thereby, we were able to demonstrate the functionality and cell compatibility of this new organ on chip test platform. The modular design of the DynaMiTES allows fast adaptation suitable for the investigation of drug permeation through other important cellular barriers.

[1]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[2]  D. Beebe,et al.  Biological implications of polydimethylsiloxane-based microfluidic cell culture. , 2009, Lab on a chip.

[3]  Yasuyuki Morita,et al.  Effect of the nanostructure of porous alumina on growth behavior of MG63 osteoblast-like cells. , 2013, Journal of bioscience and bioengineering.

[4]  Young Bin Choy,et al.  Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. , 2008, Investigative ophthalmology & visual science.

[5]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[6]  Albert van den Berg Quantitative biosciences from nano to macro Indexed in MEDLINE ! , 2012 .

[7]  D. Beebe,et al.  PDMS absorption of small molecules and consequences in microfluidic applications. , 2006, Lab on a chip.

[8]  Stephanus Büttgenbach,et al.  Microfluidic reactor for continuous cultivation of Saccharomyces cerevisiae , 2010, Biotechnology progress.

[9]  Stephan Reichl,et al.  Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.

[10]  Mandy B. Esch,et al.  TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.

[11]  Stephan Reichl,et al.  Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.

[12]  T. Sørensen,et al.  TEAR FLOW IN NORMAL HUMAN EYES. DETERMINATION BY MEANS OF RADIOISOTOPE AND GAMMA CAMERA , 1979, Acta ophthalmologica.